Moderna Inc (MRNA)

$117.07 1.12 (0.97%)

16:00 EDT MRNA Stock Quote Delayed 30 Minutes

Treasure Hunt: 3 Biotech Stocks Wall Street Hasn’t Discovered Yet

By Joey Frenette, InvestorPlace Contributor Jun 28, 2024

Undiscovered biotech stocks can be risky but rewarding, especially when it involves mid-cap stocks with promise and no profit.

7 Struggling Stocks to Sell Before July 2024

3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants

Biotech Blockbusters: 3 Pharma Stocks to Buy in June for Breakthrough Potential

Volume:

Previous Close -

Market Cap 44.84B

PE Ratio -7.48

EPS -15.66

Volume (Avg. Vol.) 3.43M

Day's Range $114.02 - $119.14

52-Week Range $62.55 - $170.47

Dividend & Yield N/A (N/A)

MRNA Stock Predictions, Articles, and Moderna Inc News

3 Sorry Biotech Stocks to Sell in May While You Still Can

By Muslim Farooque, InvestorPlace Contributor May 31, 2024

Morgan Stanley's bullish outlook highlights the need for strategic trimming of underperforming biotech stocks to sell.

3 Nasdaq Stocks to Dump as They Near Peak Performance

By Stavros Tousios, InvestorPlace Contributor May 30, 2024

Moderna, Constellation Energy and CrowdStrike are three Nasdaq stocks to sell, each offering unique exit points in a peaking market.

3 Sorry Pharma Stocks to Sell in May While You Still Can

By Matthew Farley, InvestorPlace Contributor May 29, 2024

Discover three pharma stocks to sell in May while you still can. Avoid these companies facing significant setbacks.

If You Can Only Buy One Biotech Stock in May, It Better Be One of These 3 Names

By Chandler Capital, InvestorPlace Contributor May 29, 2024

Between FDA approvals and product pipelines, it takes diligence to keep up with which biotech stocks to buy.

The Moderna News That Has MRNA Stock Price Surging This Week: 3 Key Catalysts

By Shrey Dua, InvestorPlace Assistant News Writer May 23, 2024

MRNA stock has climbed more than 20% in just the past five trading sessions. What's behind Moderna's recent rally?

3 Cathie Wood Stocks to Buy Now: May 2024

By Joey Frenette, InvestorPlace Contributor May 21, 2024

Many popular stocks are down, but it may be a mistake to discount these Cathie Wood stocks to buy as new catalysts come to be.

Just Say No to Drugs: 3 Pharma Stocks to Avoid

By Shane Neagle, InvestorPlace Contributor May 8, 2024

Discover which pharma stocks to avoid in 2023 as we delve into market trends, financial struggles, and the impact on investor portfolios.

Shhh! 3 Secret Pharma Stocks Flying Below Wall Street’s Radar

By Matthew Farley, InvestorPlace Contributor May 3, 2024

Discover three under-the-radar pharma stocks poised for significant growth in 2024. Explore their product pipelines and potential gains.

MRNA Stock Earnings: Moderna Beats EPS, Beats Revenue for Q1 2024

By InvestorPlace Earnings May 2, 2024

MRNA stock results show that Moderna beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Stock Market Crash Warning: Don’t Get Caught Holding These 3 Cathie Wood Stocks

By Ian Bezek, InvestorPlace Contributor May 2, 2024

Current economic tides have turned against Cathie Wood's style of aggressive investing, with three of her picks in particular danger.

Shhh! 3 Secret Biotech Stocks Flying Below Wall Street’s Radar

By Joey Frenette, InvestorPlace Contributor May 1, 2024

These biotech stocks seem to be rich with intriguing growth plays going for very reasonable multiples this May.

3 Biotech Stocks with Blockbuster Drug Pipelines: April Edition

By Chandler Capital, InvestorPlace Contributor Apr 30, 2024

Here are our top three choices for biotech stocks with blockbuster drug pipelines that could pay off massively in the future.

Medical AI Could Be Your Ticket to Riches: 3 Stocks to Buy

By Josh Enomoto, InvestorPlace Contributor Apr 23, 2024

While artificial intelligence may be useful for a variety of purposes – including asking silly questions we’re afraid to pose in real life – the…

3 Pharma Stocks to Sell in April Before They Crash & Burn

By Matthew Farley, InvestorPlace Contributor Apr 11, 2024

Discover three pharma stocks to sell in April, facing challenges and signaling potential for significant downside.

If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names

By Muslim Farooque, InvestorPlace Contributor Apr 11, 2024

Capitalize on the biotech sector's boom with these three top biotech stocks to buy, driven by aging demographics and advanced treatments

3 Healthcare Stocks Short Sellers Are Prescribing for Trouble

By Andy Kim, InvestorPlace Contributor Apr 5, 2024

The healthcare industry is one of the most potent yet also one of the most competitive. This has short sellers out for blood.

The 3 Most Undervalued Biotech Stocks to Buy in April 2024

By Joey Frenette, InvestorPlace Contributor Apr 5, 2024

The most undervalued biotech stocks to buy in April are intriguing value options with mature biotech plays that boast impressive pipelines.

3 Biotech Stocks That Could Be Multibaggers in the Making: March Edition

By Shane Neagle, InvestorPlace Contributor Mar 28, 2024

Discover these three biotech stocks set for major gains with groundbreaking health solutions. Invest in the future of medicine.

3 Precision Medicine Stocks That Could Benefit From the Industry’s Rise

By Matthew Farley, InvestorPlace Contributor Mar 15, 2024

Dive into the potential of precision medicine stocks poised to revolutionize healthcare and offer substantial growth opportunities.

Turnaround Plays: 3 Stocks to Buy for a Major Recovery in 2024

By Joel Baglole, InvestorPlace Contributor Mar 8, 2024

While most companies that change their plans fail, investors should pay attention to these three turnaround stocks poised for recovery.

Moderna Inc (MRNA)

Treasure Hunt: 3 Biotech Stocks Wall Street Hasn’t Discovered Yet

7 Struggling Stocks to Sell Before July 2024

3 Vaccine Stocks to Buy as the FDA Cracks Down on New Variants

Biotech Blockbusters: 3 Pharma Stocks to Buy in June for Breakthrough Potential

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Moderna Inc (MRNA)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

MRNA Stock Predictions, Articles, and Moderna Inc News

Subscriber Sign in